The Russian Health Ministry issued a statement stating that the Russian vaccine Sputnik V has passed all quality checks and has now been released for general citizens.The vaccine named Sputnik V has been developed by Gamaleya National Research Center of Epidemiology and Microbiology and Russian Direct Investment Fund. Let us know that the clinical trial of the last phase of Russia’s Coronavirus vaccine Sputnik V will start in India from this month. Kirill Dimitrij, CEO of the Russian Direct Investment Fund (RFID), the funding agency for the vaccine, said clinical trials for the vaccine would begin in India, including India, in the UAE, Saudi Arabia, the Philippines and Brazil this month.
Russia’s Health Minister Mikhail Murashko previously stated that the first at-risk groups such as teachers and doctors would be vaccinated. Earlier this month, research published in The Lancet Journal stated that the Russian Corona vaccine gave no serious side outcomes and showed an invulnerable rejoinder in the initial human experiment. Russia displayed Sputnik V last month, making it the first nation in the world to support the Kovid-19 vaccine. The Russian Ministry of Health had started to begin vaccine stock on 15 August.
However, the authors of the research published in the journal also state that larger and longer-term trials, including placebo comparisons, are needed to assure the long-term safety and effectiveness of the vaccine. The Indian administration said at the end of last month that New Delhi and Moscow were in talks about the Sputnik V vaccine. At the same time, the CEO of the Russian Direct Investment Fund, Kirill Dimitrij, said that Russia wants to partner with India to produce the Kovid-19 vaccine.